374 related articles for article (PubMed ID: 33774407)
21. Composition-dependent structural changes and antitumor activity of ASC-DP/DSPE-PEG nanoparticles.
Higashi K; Mibu F; Saito K; Limwikrant W; Yamamoto K; Moribe K
Eur J Pharm Sci; 2017 Mar; 99():24-31. PubMed ID: 27916697
[TBL] [Abstract][Full Text] [Related]
22. Amphiphilic Y shaped miktoarm star copolymer for anticancer hydrophobic and hydrophilic drugs codelivery: Synthesis, characterization, in vitro, and in vivo biocompatibility study.
Aghajanzadeh M; Zamani M; Rashidzadeh H; Rostamizadeh K; Sharafi A; Danafar H
J Biomed Mater Res A; 2018 Nov; 106(11):2817-2826. PubMed ID: 29908009
[TBL] [Abstract][Full Text] [Related]
23. A novel size-tunable nanocarrier system for targeted anticancer drug delivery.
Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS
J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.
Sadighian S; Rostamizadeh K; Hosseini-Monfared H; Hamidi M
Colloids Surf B Biointerfaces; 2014 May; 117():406-13. PubMed ID: 24675279
[TBL] [Abstract][Full Text] [Related]
25. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
[TBL] [Abstract][Full Text] [Related]
26. A New Methodology to Create Polymeric Nanocarriers Containing Hydrophilic Low Molecular-Weight Drugs: A Green Strategy Providing a Very High Drug Loading.
Villamizar-Sarmiento MG; Molina-Soto EF; Guerrero J; Shibue T; Nishide H; Moreno-Villoslada I; Oyarzun-Ampuero FA
Mol Pharm; 2019 Jul; 16(7):2892-2901. PubMed ID: 31181908
[TBL] [Abstract][Full Text] [Related]
27. Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models.
Law S; Leung AW; Xu C
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):542-559. PubMed ID: 32054336
[TBL] [Abstract][Full Text] [Related]
28. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
29. pH sensitive surfactant-stabilized Fe
Dutta B; Shetake NG; Barick BK; Barick KC; Pandey BN; Priyadarsini KI; Hassan PA
Colloids Surf B Biointerfaces; 2018 Feb; 162():163-171. PubMed ID: 29190467
[TBL] [Abstract][Full Text] [Related]
30. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
31. pH-sensitive micelles self-assembled from polymer brush (PAE-
Huang X; Liao W; Zhang G; Kang S; Zhang CY
Int J Nanomedicine; 2017; 12():2215-2226. PubMed ID: 28356738
[TBL] [Abstract][Full Text] [Related]
32. Functionalized Graphene Oxide as Drug Delivery Systems for Platinum Anticancer Drugs.
Wei L; Li G; Lu T; Wei Y; Nong Z; Wei M; Pan X; Qin Q; Meng F; Li X
J Pharm Sci; 2021 Nov; 110(11):3631-3638. PubMed ID: 34303674
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
Feng SS; Mu L; Win KY; Huang G
Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
[TBL] [Abstract][Full Text] [Related]
34. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
35. Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy.
Yang X; Grailer JJ; Pilla S; Steeber DA; Gong S
Bioconjug Chem; 2010 Mar; 21(3):496-504. PubMed ID: 20163170
[TBL] [Abstract][Full Text] [Related]
36. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
37. Sodium alginate-polyvinyl alcohol-bovin serum albumin coated Fe
Prabha G; Raj V
Mater Sci Eng C Mater Biol Appl; 2017 Oct; 79():410-422. PubMed ID: 28629035
[TBL] [Abstract][Full Text] [Related]
38. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency.
Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B
J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435
[TBL] [Abstract][Full Text] [Related]
39. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis.
Elbaz NM; Khalil IA; Abd-Rabou AA; El-Sherbiny IM
Int J Biol Macromol; 2016 Nov; 92():254-269. PubMed ID: 27397719
[TBL] [Abstract][Full Text] [Related]
40. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
